• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内分泌治疗期间局限性前列腺癌的神经内分泌分化

Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.

作者信息

Nemoto Kaoru, Tomita Yuji

机构信息

Department of Urology, National Hakodate Hospital, Hakodate, Japan.

出版信息

Scand J Urol Nephrol. 2007;41(6):558-60. doi: 10.1080/00365590701365404.

DOI:10.1080/00365590701365404
PMID:17853028
Abstract

A 74-year-old male was treated with endocrine therapy for localized prostate cancer. After 25 months he complained of a swollen neck, and was diagnosed with prostate cancer with lymph node metastasis of neuroendocrine differentiation. Neuroendocrine differentiation without elevation of conventional tumor markers is rare during the initial recurrent course of localized prostate cancer.

摘要

一名74岁男性因局限性前列腺癌接受内分泌治疗。25个月后,他抱怨颈部肿胀,被诊断为伴有神经内分泌分化淋巴结转移的前列腺癌。在局限性前列腺癌的初始复发过程中,神经内分泌分化而传统肿瘤标志物不升高的情况很少见。

相似文献

1
Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.内分泌治疗期间局限性前列腺癌的神经内分泌分化
Scand J Urol Nephrol. 2007;41(6):558-60. doi: 10.1080/00365590701365404.
2
[Giant prostate carcinoma treated effectively with endocrine therapy: case report].[内分泌治疗有效治疗巨大前列腺癌:病例报告]
Hinyokika Kiyo. 2007 Feb;53(2):133-5.
3
[Solitary peritoneal carcinomatosis in prostate cancer].[前列腺癌中的孤立性腹膜癌转移]
Aktuelle Urol. 2007 Sep;38(5):408-9. doi: 10.1055/s-2007-959185.
4
Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.前列腺特异性抗原半衰期与治疗前前列腺特异性抗原:延迟联合雄激素阻断治疗中前列腺特异性抗原变化趋势的关键预测因素
Int J Urol. 2007 Mar;14(3):192-6; discussion 197. doi: 10.1111/j.1442-2042.2007.01671.x.
5
Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.
Urology. 2004 Oct;64(4):807-9. doi: 10.1016/j.urology.2004.05.042.
6
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma.非甾体类抗雄激素单药治疗与去势治疗对前列腺癌神经内分泌分化的影响
Urology. 2004 Mar;63(3):523-7. doi: 10.1016/j.urology.2003.10.043.
7
[Reevaluation of MAB therapy and progress of endocrine therapy].[单克隆抗体疗法的重新评估及内分泌疗法的进展]
Gan To Kagaku Ryoho. 2005 May;32(5):705-28.
8
[Regression of a choroidal metastasis from prostate adenocarcinoma after hormonal therapy].[激素治疗后前列腺腺癌脉络膜转移灶的消退]
Arch Soc Esp Oftalmol. 2007 Nov;82(11):715-7.
9
Development of carcinoid tumour in hormonally treated adenocarcinoma of the prostate.前列腺腺癌激素治疗后发生类癌瘤。
Eur Urol. 2009 Nov;56(5):874-7; quiz 876. doi: 10.1016/j.eururo.2009.01.019. Epub 2009 Jan 20.
10
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.初始最大雄激素阻断治疗后复发的晚期前列腺癌的替代性非甾体抗雄激素治疗
J Urol. 2008 Sep;180(3):921-7. doi: 10.1016/j.juro.2008.05.045. Epub 2008 Jul 17.